Literature DB >> 11606502

Lack of inducible nitric oxide synthase promotes intestinal tumorigenesis in the Apc(Min/+) mouse.

D J Scott1, M A Hull, E J Cartwright, W K Lam, A Tisbury, R Poulsom, A F Markham, C Bonifer, P L Coletta.   

Abstract

BACKGROUND & AIMS: The role of the inducible isoform of nitric oxide synthase (Nos2 or iNOS) in intestinal tumorigenesis is unclear. Conflicting data also exist regarding the ability of Nos2 to modulate expression and/or activity of cyclooxygenase 2 (Cox-2), which promotes intestinal tumorigenesis. Therefore, we determined the effect of a null Nos2 genotype on intestinal tumorigenesis and Cox-2 expression/activity in the Apc(Min/+) mouse model of familial adenomatous polyposis.
METHODS: Apc(Min/+)Nos2(-/-) mice were generated by successive crosses between C57BL/6-Apc(Min/+) and C57BL/6-Nos2(tm1Lau) mice. Adenoma characteristics of age-matched Apc(Min/+)Nos2(+/+) and Apc(Min/+)Nos2(-/-) mice were compared. The level and cellular localization of Nos2 messenger RNA (mRNA) expression in Apc(Min/+)Nos2(+/+) mouse intestine was determined. Cox-2 expression and activity were measured in both intestinal tissue and bone marrow-derived macrophages in vitro.
RESULTS: Apc(Min/+)Nos2(-/-) mice developed significantly more intestinal adenomas than Apc(Min/+)Nos2(+/+) littermates. Epithelial cell Nos2 mRNA expression was decreased in adenomas compared with histologically normal Apc(Min/+)Nos2(+/+) intestine. There was no significant difference in Cox-2 expression or activity in either intestine or bone marrow-derived macrophages from Apc(Min/+)Nos2(+/+) and Apc(Min/+)Nos2(-/-) animals.
CONCLUSIONS: Nos2 plays an antineoplastic role in the Apc(Min/+) mouse model of familial adenomatous polyposis. Nos2 does not modulate Cox-2 expression or activity in the Apc(Min/+) mouse.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11606502     DOI: 10.1053/gast.2001.27994

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  23 in total

Review 1.  Nitric oxide and cancer therapy: the emperor has NO clothes.

Authors:  Jason R Hickok; Douglas D Thomas
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

2.  Ornithine Decarboxylase in Macrophages Exacerbates Colitis and Promotes Colitis-Associated Colon Carcinogenesis by Impairing M1 Immune Responses.

Authors:  Kshipra Singh; Lori A Coburn; Mohammad Asim; Daniel P Barry; Margaret M Allaman; Chanjuan Shi; M Kay Washington; Paula B Luis; Claus Schneider; Alberto G Delgado; M Blanca Piazuelo; John L Cleveland; Alain P Gobert; Keith T Wilson
Journal:  Cancer Res       Date:  2018-05-31       Impact factor: 12.701

3.  Colorectal carcinoma development in inducible nitric oxide synthase-deficient mice with dextran sulfate sodium-induced ulcerative colitis.

Authors:  Darren N Seril; Jie Liao; Guang-Yu Yang
Journal:  Mol Carcinog       Date:  2007-05       Impact factor: 4.784

4.  Evaluation of iNOS Expression in Esophageal Cancer Patients.

Authors:  Romina Barani; Gholamreza Motalleb; Hossein Maghsoudi
Journal:  Gastrointest Tumors       Date:  2016-03-17

Review 5.  iNOS expression in oral and gastrointestinal tract mucosa.

Authors:  Nurullah Keklikoglu; Meltem Koray; Humeyra Kocaelli; Sevtap Akinci
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

6.  Expression of inducible nitric oxide synthase is increased in rat Barrett's esophagus induced by duodenal contents reflux.

Authors:  Jong Dae Bae; Ki Hoon Jung; Woo Sup Ahn; Sung Han Bae; Tae Jung Jang
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

7.  In vivo modulation of iNOS pathway in hepatocellular carcinoma by Nigella sativa.

Authors:  Moustafa Fathy; Toshio Nikaido
Journal:  Environ Health Prev Med       Date:  2013-04-23       Impact factor: 3.674

8.  Hypoxic inducible factor 1alpha, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide.

Authors:  Douglas D Thomas; Michael Graham Espey; Lisa A Ridnour; Lorne J Hofseth; Daniele Mancardi; Curtis C Harris; David A Wink
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-03       Impact factor: 11.205

9.  Vanin-1(-/-) mice show decreased NSAID- and Schistosoma-induced intestinal inflammation associated with higher glutathione stores.

Authors:  Florent Martin; Marie-France Penet; Fabrice Malergue; Hubert Lepidi; Alain Dessein; Franck Galland; Max de Reggi; Philippe Naquet; Bouchra Gharib
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

10.  Arginase acts as an alternative pathway of L-arginine metabolism in experimental colon anastomosis.

Authors:  M B Witte; N Vogt; C Stuelten; T Gotoh; M Mori; H D Becker
Journal:  J Gastrointest Surg       Date:  2003 Mar-Apr       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.